ALFA Filings
Every announcement, straight from the exchange
Every Sun Pharmaceutical Industries price movement clarification announcement on NSE and BSE, newest first, each with its own page.
Time
2 announcements
Sun Pharma said a 30 October 2026 news report concerned August 2026 developments, not new events. It confirmed no undisclosed material information explains the share price movement.
Sun Pharmaceutical Industries clarified that news regarding a potential $12 billion deal with Organon is speculative. The company stated there is no material information requiring disclosure under Regulation 30. Sun Pharma maintains high governance standards and will inform exchanges of any future material events as required.